100 related articles for article (PubMed ID: 3982746)
21. The effect of a 15(S)-15-methyl prostaglandin F2 alpha (methyl ester) suppository upon termination of early pregnancy.
Roux JF; Southern E; Gutknecht G
Contraception; 1980 Jul; 22(1):57-61. PubMed ID: 7418407
[TBL] [Abstract][Full Text] [Related]
22. Vaginal administration of 15-methyl-PGF2 alpha methyl ester for preoperative cervical dilatation. Task force on prostaglandins for fertility regulation. The World Health Organization.
Contraception; 1981 Mar; 23(3):251-9. PubMed ID: 7016432
[TBL] [Abstract][Full Text] [Related]
23. Treatment with a single vaginal suppository containing 15-methyl PGF2 alpha methyl ester at expected time of menstruation.
Kinoshita K; Eneroth P; Bygdeman M
Prostaglandins; 1979 Mar; 17(3):469-81. PubMed ID: 472340
[TBL] [Abstract][Full Text] [Related]
24. Preoperative cervical dilatation with a single long-acting prostaglandin analog suppository. An alternative to traumatic mechanical dilatation before surgical evacuation.
Kent DR; Goldstein AI; Milokovich D
J Reprod Med; 1983 Nov; 28(11):778-80. PubMed ID: 6655636
[TBL] [Abstract][Full Text] [Related]
25. Menstrual regulation with prostaglandin analogues.
Hagenfeldt K; Bygdeman M
Reproduccion; 1981; 5(3):195-201. PubMed ID: 7026317
[TBL] [Abstract][Full Text] [Related]
26. Use of prostaglandin E2 vaginal suppositories in intrauterine fetal death and missed abortion.
Bailey CD; Newman C; Ellinas SP; Anderson GG
Obstet Gynecol; 1975 Jan; 45(1):110-3. PubMed ID: 1110809
[TBL] [Abstract][Full Text] [Related]
27. Postconceptional induction of menses with double prostaglandin F2 alpha impact.
Borten M; Friedman EA
Am J Obstet Gynecol; 1984 Dec; 150(8):1006-7. PubMed ID: 6507528
[TBL] [Abstract][Full Text] [Related]
28. Quantitation of uterine activity after vaginal administration of prostaglandins.
Henzl MR; Arvealo TN; Noriega L; Aznar R; Ortega E; Segre E
Adv Biosci; 1973; 9():767-72. PubMed ID: 4805889
[TBL] [Abstract][Full Text] [Related]
29. The role of a long-acting vaginal suppository of 15-ME-PGF2 alpha in first and second trimester abortion.
Lauersen NH; Wilson KH
Adv Prostaglandin Thromboxane Res; 1980; 8():1435-41. PubMed ID: 7376994
[No Abstract] [Full Text] [Related]
30. Early midtrimester pregnancy termination. A comparison of dilatation and evacuation and intravaginal prostaglandin E2.
Robins J; Surrago EJ
J Reprod Med; 1982 Jul; 27(7):415-9. PubMed ID: 6956734
[TBL] [Abstract][Full Text] [Related]
31. Comparison between intraamniotic PGF2 alpha and vaginal PGE2 for second-trimester abortion.
Lebed JP; Rubin A; Millman AE
Obstet Gynecol; 1980 Jul; 56(1):90-6. PubMed ID: 7383493
[TBL] [Abstract][Full Text] [Related]
32. Abortifacient efficiency of 15 (S) 15-methyl-prostaglandin F2alpha-methyl ester administered vaginally during early pregnancy.
Ylikorkala O; Järvinen PA; Puukka M; Viinikka L
Prostaglandins; 1976 Oct; 12(4):609-24. PubMed ID: 973006
[TBL] [Abstract][Full Text] [Related]
33. [Termination of pregnancy with 16,16-dimethyl-trans-delta2 PGE1 methyl ester vaginal suppositories: an analysis of 182 cases].
Du MK; Ying YD; Zheng HM; Yuan YE; Zhu Y
Shengzhi Yu Biyun; 1982 Jun; 2(2):28-31. PubMed ID: 12279680
[TBL] [Abstract][Full Text] [Related]
34. Early pregnancy interruption with two 15-ME-PGF2a suppositories.
Lauersen NH; Wilson KH
Contraception; 1980 Mar; 21(3):273-82. PubMed ID: 7389352
[TBL] [Abstract][Full Text] [Related]
35. Mid-trimester abortion induced by intravaginal administration of prostaglandin E2 suppositories.
Lauersen NH; Secher NJ; Wilson KH
Am J Obstet Gynecol; 1975 Aug; 122(8):947-54. PubMed ID: 1155530
[TBL] [Abstract][Full Text] [Related]
36. Early complications and sequence of pregnancy interruption with hypertonic saline.
Borenstein R; Ashkenazy M; Lancet M
Int J Fertil; 1980; 25(2):88-93. PubMed ID: 6117532
[TBL] [Abstract][Full Text] [Related]
37. Misoprostol for abortion at 9-12 weeks' gestation in adolescents.
Carbonell JL; Velazco A; Varela L; Tanda R; Sánchez C; Barambio S; Chami S; Valero F; Aragón S; Marí J
Eur J Contracept Reprod Health Care; 2001 Mar; 6(1):39-45. PubMed ID: 11334475
[TBL] [Abstract][Full Text] [Related]
38. [Clinical study of a new protocol on the termination of early pregnancy by administration of dl-15-methyl prostaglandin F2 alpha in combination with testosterone propionate].
Zhou YF
Shengzhi Yu Biyun; 1988 Aug; 8(3):18-22. PubMed ID: 12281924
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of vaginal prostaglandin E2 suppositories in the management of third-trimester fetal demise.
Kent DR; Goldstein AI; Linzey EM
J Reprod Med; 1984 Feb; 29(2):101-2. PubMed ID: 6584630
[TBL] [Abstract][Full Text] [Related]
40. Clinical application of prostaglandins in obstetrics and gynecology.
Brunnberg FJ
Acta Biol Med Ger; 1976; 35(8-9):1243-7. PubMed ID: 1007783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
